Analysen von James Gordon
| 16.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.09.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 09.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.08.19 | Alcon Neutral | JP Morgan Chase & Co. | |
| 21.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 14.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.08.19 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.08.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 07.08.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 30.07.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.07.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 27.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.06.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 04.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 28.05.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.05.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 08.05.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 26.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.04.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 11.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 04.04.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.03.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 11.03.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.01.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 14.01.19 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 12.12.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 07.12.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 06.12.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 03.12.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.11.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.11.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.11.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 01.11.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.10.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.10.18 | GSK Neutral | JP Morgan Chase & Co. | |